Navigation Links
New DNA-Based Blood Test May Spot Signs of Cancer
Date:11/28/2012

By Randy Dotinga
HealthDay Reporter

WEDNESDAY, Nov. 28 (HealthDay News) -- A new study raises the possibility of a DNA-based blood test that doctors could routinely use to determine whether a patient has cancer.

There are many caveats. The research is preliminary, and the test is not cheap. Even if it does detect cancer, the test -- like the one currently used to detect prostate cancer -- could raise big questions about how to deal with the results.

Even so, a genetic test for cancer would be a major advance, experts say.

"This would be a way of detecting cancers earlier, and to tell you the level of cancer as you're going through the therapy," said Dr. Victor Velculescu, co-director of the Cancer Biology Program at Johns Hopkins Kimmel Cancer Center in Baltimore.

Several blood tests detect the body's reaction to cancer, and others are being developed, including one that may spot stray cancer cells in the blood. This test is unique because it examines the blood for signs of DNA that's spilled out of cancerous cells into the bloodstream when they die, Velculescu explained.

In the study, researchers found that the test picked up differences in 10 patients with breast or colorectal cancer when compared to 10 healthy patients. The test didn't falsely suggest any of the healthy patients had cancer, he added.

"We're looking at the entire genome and can apply the test to any cancer type or individual cancer," Velculescu said.

The test costs hundreds of thousands of dollars, but Velculescu expects the price would eventually drop.

In the future, he said, the test could be performed at regular intervals and detect cancer without requiring a biopsy. For now, however, the test needs to undergo more research.

There's one possible complication: If the test detects signs of cancer, then what? A blood screening test for prostate cancer, known as the PSA test, is a topic of hot debate because some patients may undergo unnecessary treatment.

Still, Dr. Otis Brawley, chief medical officer and executive vice president of the American Cancer Society, said he can foresee a cancer screening blood test becoming a routine part of medicine, although it may take 20 years or more to get there.

In some cases, Brawley said, doctors could potentially choose to use the screening test to evaluate the extent of cancer in a patient instead of performing a biopsy. For example, in certain types of lung cancer, a biopsy can be dangerous because a needle is inserted into the lung, he noted.

For now, Brawley said, the test is "extremely expensive and extremely preliminary, and it's probably several years before anybody's going to be able to buy this."

The study appears in the Nov. 28 issue of the journal Science Translational Medicine.

More information

For more about cancer, visit the U.S. National Library of Medicine.

SOURCES: Victor Velculescu, M.D., Ph.D., associate professor, oncology, and co-director, Cancer Biology Program, Kimmel Cancer Center, Johns Hopkins University, Baltimore; Otis Brawley, M.D., chief medical officer and executive vice president, American Cancer Society, Atlanta; Nov. 28, 2012, Science Translational Medicine


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Johns Hopkins scientists pair blood test and gene sequencing to detect cancer
2. High Blood Pressure During Pregnancy Tied to Later Heart Trouble
3. Impaired blood vessel function found in cystic fibrosis patients
4. Pathway identified in human lymphoma points way to new blood cancer treatments
5. Genetic factor holds key to blood vessel health
6. Exercise benefits found for pregnancies with high blood pressure
7. Human umbilical cord blood cell co-culture supports embryonic stem cell expansion
8. G proteins regulate remodelling of blood vessels
9. No Need to Fast Before Cholesterol Blood Test: Study
10. Drinking green tea with starchy food may help lower blood sugar spikes
11. Diabetes study: Mindful eating equals traditional education in lowering weight and blood sugar
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New DNA-Based Blood Test May Spot Signs of Cancer
(Date:10/13/2017)... WI (PRWEB) , ... October 13, 2017 , ... As ... in medicine known as “patient engagement.” The patient is doing more than filling out ... partners. , “There is an increasing emphasis in health care and research on ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... PurhealthRX ... CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will ... and providing a CBD form that can be easily incorporated into liquid products, while ...
(Date:10/13/2017)... LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for care ... is the 90-day elimination period, when the family pays for care, is often waived, ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The ... the most popular and least understood books in the Holy Scriptures, Revelation. The Book ... have baffled scholars for centuries. Many have tossed it off as mere rubbish, but ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history of ... Brink” is the creation of published author, William Nowers. Captain Nowers and his ... veteran, he spent thirty years in the Navy. Following his career as a ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... -- Hill-Rom Holdings, Inc. (NYSE: HRC), will host its ... on Friday, November 3, 2017, beginning at 7:00 a.m. ... 8:30 a.m. (CDT) / 9:30 a.m. (EDT). ... and guidance for 2018, Hill-Rom executives will also highlight ... and long-range financial outlook through 2020. ...
(Date:9/25/2017)... PROVIDENCE, R.I. , Sept. 25, 2017 /PRNewswire/ ... immunogenicity assessment, vaccine design, and immune-engineering today announced ... focused on the development of personalized therapeutic cancer ... and has provided exclusive access to enabling technologies ... MSc Eng., MBA will lead EpiVax Oncology as ...
(Date:9/19/2017)... Ky. , Sept. 19, 2017   ZirMed Inc ... predictive analytics, today announced that it has been ranked #1 ... Black Book™ Rankings 2017 User Survey. ZirMed was ... solution for large hospitals and medical centers over 200 beds ... Black Book,s healthcare technology user survey history. ...
Breaking Medicine Technology: